DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAFoundation

Haemoptysis

Essential points for quick revision.

!
Escalate

Haemoptysis becomes life-threatening when bleeding threatens airway patency, ventilation or circulation, regardless of an imprecise reported volume. Sit the patient appropriately, call anaesthetic, respiratory, interventional-radiology and thoracic support early, correct physiological compromise and avoid leaving an actively bleeding patient unattended for diagnostic tests.

Synopsis

Confirm true lower-respiratory bleeding, protect the airway in life-threatening haemoptysis, and identify malignancy, infection, bronchiectasis, vascular disease and treatment-related bleeding through a severity-led investigation pathway.

  • First confirm the source: haemoptysis is coughed from below the larynx, while epistaxis, oral bleeding and haematemesis require different pathways.
  • Severity is physiological, not purely volumetric. Airway flooding, impaired gas exchange, haemodynamic instability or continuing brisk bleeding defines an emergency even when volume is uncertain.
  • Ask about lung-cancer risk, bronchiectasis, tuberculosis exposure, infection, pulmonary embolism, autoimmune disease, recent procedures and anticoagulant or antiplatelet treatment.

Key red flags

Life-threatening haemoptysis

Active bleeding with inability to clear blood, falling saturation, respiratory distress, reduced consciousness, hypotension or a rapidly filling airway requires simultaneous resuscitation and haemorrhage control. Reported millilitres should not delay escalation.

Investigation priorities

01
ABCDE assessment, continuous oximetry and quantified bleeding trendFirst step

Determine whether haemoptysis is immediately threatening airway, ventilation or circulation.

Management branches

EmergencyLife-threatening active bleeding

Airway contamination, gas-exchange failure, haemodynamic compromise or continuing brisk haemoptysis.

  1. Activate major clinical support including anaesthesia, respiratory, interventional radiology and thoracic surgery; use high-flow suction, monitoring, large-bore access and blood preparation while protecting staff and patient.
  2. If the bleeding side is known, position that lung dependent where feasible to protect the other lung; provide oxygen and ventilation support, recognising that a large single-lumen airway may be required for suction and bronchoscopy.
StableNon-massive haemoptysis assessment

Blood-streaking or small-volume haemoptysis with stable airway, oxygenation and haemodynamics.

Key medicines

Agent-specific anticoagulant reversalUse the locally adopted major-bleeding protocol for the exact anticoagulant, last dose, renal function and bleeding severity; obtain urgent haematology advice.
Antimicrobial therapy for a confirmed infective causeSelect agent, route and duration from the relevant pneumonia, bronchiectasis or tuberculosis guideline and current microbiology rather than treating haemoptysis empirically.
Open full textbook Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom